# Belatacept for Renal Transplant Recipients With Delayed Graft Function

> **NCT02134288** · EARLY_PHASE1 · TERMINATED · sponsor: **Ohio State University** · enrollment: 8 (actual)

## Conditions studied

- Delayed Graft Function

## Interventions

- **DRUG:** Belatacept
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT02134288
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2018-12-11
- **Final completion:** 2019-01-18
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Drug unavailability due to a manufacturing transition.
- **Last updated:** 2021-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02134288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02134288, "Belatacept for Renal Transplant Recipients With Delayed Graft Function". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02134288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*